Clinical Guides
Hypoparathyroidism
A clinically focused, India-adapted guide to diagnosing parathyroid hormone deficiency, treating acute hypocalcaemia, individualizing calcium and active vitamin D, protecting the kidneys, managing pregnancy and appraising PTH replacement.
MedNext Academy | 14 min read
Hypoparathyroidism
A clinically focused, India-adapted guide to diagnosing parathyroid hormone deficiency, treating acute hypocalcaemia, individualizing calcium and active vitamin D, protecting the kidneys, managing pregnancy and appraising PTH replacement.
Summary
Hypoparathyroidism is an endocrine disorder in which absent or insufficient parathyroid hormone action causes hypocalcaemia, usually with hyperphosphataemia and reduced renal activation of vitamin D. The commonest adult cause is injury, devascularization or removal of parathyroid tissue during thyroid, parathyroid or other neck surgery. Autoimmune, genetic, infiltrative and radiation-related forms are less common. Severe magnesium depletion can suppress parathyroid hormone secretion and action, producing a reversible functional picture that must be corrected before permanent disease is diagnosed. Chronic postsurgical hypoparathyroidism is now generally defined only after persistence beyond twelve months because recovery can occur later than previously assumed.
Acute symptomatic hypocalcaemia is a medical emergency. Perioral tingling and cramps may progress to carpopedal spasm, laryngospasm, seizures, prolonged QT and arrhythmia. Obtain an ECG and calcium, magnesium, phosphate, renal function and parathyroid hormone samples without delaying intravenous calcium when the patient is unstable. Chronic treatment differs: use oral calcium and an activated vitamin D analogue, maintain native vitamin D and magnesium, and target symptom control with calcium in the lower reference range rather than forcing high-normal values. Excess treatment can cause hypercalciuria, stones, nephrocalcinosis and kidney impairment because the renal calcium-conserving effect of PTH is absent. Monitoring must therefore include urine as well as blood. PTH replacement can reduce supplement burden and improve biochemical control in selected adults whose disease remains uncontrolled, but availability, cost, long-term outcome evidence, pregnancy safety and product-specific authorization limit its role. This quarantined draft requires organizational clinical review before publication.
How Common Is It?
Hypoparathyroidism is rare, with the 2025 European Society of Endocrinology guideline summarizing prevalence estimates from approximately 6.4 to 38 per 100,000 people. Estimates differ because health systems use different biochemical definitions, time thresholds and administrative codes. At least three quarters of adult cases in many cohorts follow anterior neck surgery, making operative volume, case complexity and follow-up practice major determinants of local burden. Temporary low parathyroid function after thyroidectomy is substantially more common than permanent disease. Labelling it chronic too early is inaccurate and may obscure recovery; persistent postsurgical hypoparathyroidism is defined after more than twelve months, while periodic reassessment can still identify late recovery.
Non-surgical disease includes autoimmune polyglandular syndrome type 1, activating calcium-sensing receptor variants, DiGeorge syndrome and other genetic or developmental disorders. Their relative frequency is much lower but they matter because associated candidiasis, adrenal insufficiency, renal calcium wasting, hearing loss, dysmorphism or family risk alters management. Pseudohypoparathyroidism is not true hormone deficiency: PTH is elevated because target tissues are resistant, so it belongs in the differential rather than the same prevalence category.
Reliable Indian population estimates are limited. Tertiary surgical series cannot be extrapolated to all hospitals because thyroid disease patterns, surgeon experience, calcium surveillance and discharge pathways vary. The practical burden also includes repeated emergency visits, high tablet requirements, kidney complications, impaired concentration and quality of life. These outcomes are not captured by prevalence alone. A quality programme should record post-neck-surgery calcium and PTH, distinguish transient from chronic disease, and monitor renal and patient-reported outcomes rather than count diagnoses only.
Risk Factors
Recent thyroidectomy, parathyroidectomy, central neck dissection, laryngectomy or other extensive neck surgery is the principal risk context. Risk rises with bilateral exploration, reoperation, malignant or inflammatory thyroid disease, distorted anatomy, inadvertent gland removal and compromised parathyroid blood supply. Acute symptoms commonly appear within the first postoperative days, but hungry bone syndrome after parathyroid surgery is a different mechanism involving rapid skeletal calcium uptake and often substantial magnesium and phosphate needs. Prior neck irradiation, infiltrative disease, iron or copper overload and metastatic destruction are less frequent acquired causes.
Autoimmune hypoparathyroidism may occur alone or with autoimmune polyglandular syndrome type 1, where chronic mucocutaneous candidiasis and adrenal insufficiency are critical associated clues. Genetic causes include 22q11.2 deletion, GCM2 and GNA11 disorders, and activating calcium-sensing receptor variants. The last can produce disproportionate urinary calcium loss; aggressive calcium normalization may worsen nephrocalcinosis. A family history of hypocalcaemia, seizures, deafness, renal anomalies, candidiasis, developmental features or early-onset disease should prompt genetic evaluation rather than a label of idiopathic disease.
Drugs and physiology can worsen established disease. Proton-pump inhibitors may reduce absorption of calcium carbonate, loop diuretics increase urinary calcium, glucocorticoids reduce intestinal absorption, and antiresorptive agents can precipitate hypocalcaemia in susceptible patients. Pregnancy and lactation alter calcitriol and PTH-related peptide, so supplement needs may rise or fall unpredictably. Low dietary calcium, vitamin D deficiency, diarrhoea, malabsorption and poor adherence destabilize control. Severe hypomagnesaemia suppresses PTH and makes hypocalcaemia refractory to calcium until magnesium is replaced. Chronic kidney disease complicates interpretation because secondary hyperparathyroidism usually raises PTH; a low or inappropriately normal PTH in genuine hypocalcaemia remains the defining clue.
Diagnosis
History
Ask about neck surgery and its date, postoperative tingling or spasms, previous calcium results, current elemental calcium and vitamin D formulations, missed doses and medicine interactions. Elicit perioral or acral paraesthesia, cramps, carpopedal spasm, stridor, seizures, palpitations, fatigue, cognitive symptoms, cataract and renal-stone history. Record diarrhoea, bariatric or intestinal disease, alcohol use, nutrition, pregnancy or lactation and family or syndromic clues. Distinguish an established chronic disorder from an acute postoperative fall and ask whether the patient has an emergency card or prior intravenous calcium requirement.
Examination
Assess airway, breathing, circulation and mental state first. Look for tetany, carpopedal spasm, laryngospasm, hyperreflexia and seizures; Chvostek and Trousseau signs can support but neither safely excludes disease. Record heart rate, blood pressure, hydration and a 12-lead ECG for QT prolongation or arrhythmia when symptomatic or markedly hypocalcaemic. Examine the neck scar, teeth, skin, nails and eyes, and seek candidiasis or syndromic features.
Investigations
Confirm low ionized calcium or albumin-adjusted total calcium with an inappropriately low or normal intact PTH. Repeat in stable patients to avoid diagnosing a persistent disorder from one transient sample, but do not delay emergency treatment. Measure phosphate, magnesium, creatinine and eGFR, alkaline phosphatase and 25-hydroxyvitamin D. Interpret calcium alongside acid-base status because alkalosis lowers ionized calcium without necessarily changing total calcium. Obtain urinary calcium—preferably a 24-hour collection with creatinine—once stable, and assess stones or renal imaging when symptoms or risk factors justify it. In unexplained non-surgical disease, evaluate autoimmune, genetic and syndromic causes. After surgery, duration matters: persistence beyond twelve months supports chronic postsurgical disease, while annual PTH reassessment can detect recovery.
Differential Diagnosis
Vitamin D deficiency, malabsorption and chronic kidney disease commonly cause hypocalcaemia but normally provoke secondary elevation of PTH. A low or inappropriately normal PTH therefore redirects the differential toward hypoparathyroidism, severe magnesium depletion or assay problems. Hypomagnesaemia can both inhibit secretion and cause resistance; calcium may remain refractory until magnesium is corrected. Acute pancreatitis, sepsis, massive transfusion through citrate binding, tumour lysis, rhabdomyolysis and hyperphosphataemia can produce acute hypocalcaemia through mechanisms that do not represent chronic gland failure. Antiresorptive medicines, cinacalcet, foscarnet and some chemotherapy agents should be sought explicitly.
Pseudohypoparathyroidism causes end-organ PTH resistance, so PTH is elevated rather than deficient; phenotype and genetic testing may identify Albright hereditary osteodystrophy or related disorders. Activating calcium-sensing receptor disease can resemble idiopathic hypoparathyroidism but often features marked urinary calcium for the serum calcium level and a family history. Hungry bone syndrome after successful parathyroidectomy causes prolonged skeletal uptake, generally with high bone-turnover markers and a different phosphate pattern from simple parathyroid loss. Postoperative dilution, low albumin and alkalosis may lower measured total or ionized calcium transiently.
Symptoms are nonspecific. Panic, hyperventilation and epilepsy can mimic tingling or spasm, yet respiratory alkalosis itself may lower ionized calcium and provoke real tetany. A normal total calcium does not exclude low ionized calcium during marked alkalosis. Conversely, low albumin can produce a low total value without physiologically important hypocalcaemia; direct ionized measurement is preferred when critically ill, pregnant, acid-base disturbed or when corrected formulas are unreliable. The diagnosis is a biochemical relationship among calcium, PTH, magnesium, phosphate and context—not a symptom, scar or single adjusted result.
Management
Severe hypocalcaemia—commonly calcium below 1.9 mmol/L or symptoms at any value below the local range—is an emergency. Place the patient on ECG monitoring, secure venous access, sample calcium, magnesium, phosphate, renal function and PTH, and treat seizures or airway compromise. Society guidance gives 10–20 mL of 10% calcium gluconate diluted in 50–100 mL 5% dextrose over ten minutes, repeatable until symptoms settle, followed when required by 100 mL of 10% calcium gluconate in one litre of saline or 5% dextrose at 50–100 mL/hour, titrated to response. Verify local ampoule strength and elemental calcium; calcium chloride is more irritant and ordinarily needs central access. Replace magnesium and begin active vitamin D once feasible.
For chronic disease, individualize divided oral elemental calcium with calcitriol or alfacalcidol, maintain native vitamin D and adequate magnesium, and aim for freedom from symptoms with ionized or adjusted calcium in the lower reference range. Keep phosphate and magnesium within range and avoid hypercalciuria. Calcium carbonate is inexpensive and best absorbed with food and gastric acid; calcium citrate may be useful with achlorhydria, proton-pump inhibition or poor carbonate tolerance but costs more. Take calcium separately from levothyroxine, iron and medicines whose absorption it impairs.
If urinary calcium is high, review over-replacement, lower sodium intake, distribute calcium with meals and consider a thiazide under blood-pressure, sodium, potassium and renal monitoring. PTH replacement is a specialist option for persistent symptoms, poor biochemical control, hypercalciuria, hyperphosphataemia, renal concerns or an intolerable pill burden despite optimized conventional care. It can reduce supplements and improve biochemical measures; robust evidence for preventing fractures, chronic kidney disease, calcification, mortality or all quality-of-life outcomes remains limited.
Prescribing Information
Prescribe calcium by elemental calcium content, not tablet weight. Different salts contain different proportions, and brand switching can change the delivered dose. Divide larger daily requirements to improve absorption and reduce gastrointestinal effects. Calcium carbonate requires gastric acid and should generally be taken with meals; citrate is less acid-dependent. Separate calcium from levothyroxine and selected antibiotics, bisphosphonates and iron according to their product instructions. Constipation, bloating and adherence burden are common. Excess calcium with active vitamin D can cause hypercalcaemia and hypercalciuria even when the patient previously remained low.
Calcitriol and alfacalcidol bypass the PTH-dependent renal activation step and are central chronic therapies. Their rapid biological effect is useful for titration but means toxicity can emerge after dose changes, kidney injury or reduced intake. Check calcium, phosphate, magnesium and creatinine within one to two weeks after a meaningful change, sooner when clinically unstable. Native cholecalciferol or ergocalciferol maintains vitamin D stores but is not a substitute for activated vitamin D in established hormone deficiency. Correct magnesium using a route and rate appropriate to severity and renal function.
Intravenous calcium is a high-alert medicine. Use ECG monitoring for severe symptoms, verify concentration, avoid extravasation and seek pharmacy or critical-care support for continuous infusions. Calcium chloride delivers more elemental calcium and is more damaging peripherally; never substitute equal volumes for calcium gluconate. Digoxin exposure and major renal impairment require additional specialist caution. Thiazides may reduce urine calcium but can cause hyponatraemia, hypokalaemia, hypotension and gout. PTH replacement requires product-specific titration with reduction of calcium and active vitamin D to prevent hypercalcaemia. Do not assume teriparatide osteoporosis dosing is approved or physiologic treatment for hypoparathyroidism, and avoid PTH analogues in pregnancy because safety has not been established.
When to Refer
Seek emergency medicine, anaesthesia or critical-care help for stridor, laryngospasm, seizure, significant QT prolongation, arrhythmia, haemodynamic instability or symptoms requiring repeated calcium boluses and infusion. Endocrinology should be involved early in severe or recurrent episodes, refractory hypocalcaemia, renal impairment, substantial magnesium disturbance and suspected hypoparathyroidism after neck surgery. The operating team must know about acute postoperative decline, expanding neck swelling, airway concern or possible hungry bone syndrome. Do not discharge a recently operated patient until symptoms, calcium trajectory, medicine supply, written monitoring and follow-up are safe.
Refer chronic disease when control requires high supplement doses, symptoms persist despite acceptable calcium, phosphate remains high, urinary calcium is excessive, eGFR falls, stones or nephrocalcinosis occur, adherence is limited by pill burden, or PTH replacement is being considered. Nephrology input is valuable for kidney impairment, stones and difficult urine-calcium management. Clinical genetics is appropriate for non-surgical young-onset disease, family history, syndromic features or suspected calcium-sensing receptor disorder. Evaluate autoimmune polyglandular syndrome urgently if candidiasis coexists with weakness, pigmentation, hypotension or electrolyte features of adrenal insufficiency.
Pregnancy should be planned with endocrinology and obstetric medicine before conception. Once pregnant, coordinate serial ionized or adjusted calcium, phosphate, magnesium, renal function and symptom review; changing requirements are expected. Paediatric endocrine input is required for children and for neonatal calcium surveillance when maternal disease may affect fetal-neonatal mineral balance. In India, refer to a centre capable of reliable ionized calcium, PTH, 24-hour urine assessment and endocrine-nephrology collaboration when local monitoring cannot safely support dose changes or advanced therapy.
Red Flags
Airway noise, laryngospasm, generalized tetany, seizure, syncope, confusion, heart failure, prolonged QT or ventricular arrhythmia are immediate red flags. Symptoms at any calcium below the local range can be severe; an apparently modest adjusted value should not delay treatment when ionized calcium is low and the patient is unstable. Post-thyroidectomy tingling that progresses over hours, inability to swallow tablets, vomiting or a falling serial calcium needs urgent reassessment. Neck swelling or respiratory difficulty may represent a surgical airway emergency as well as hypocalcaemia.
Refractory hypocalcaemia should prompt an immediate magnesium result, infusion review, active-vitamin-D plan and reconsideration of the diagnosis. Hyperphosphataemia, pancreatitis, tumour lysis, sepsis and citrate exposure can change treatment needs. During intravenous calcium, extravasation, bradycardia, arrhythmia or rapidly rising calcium requires stopping or adjusting therapy and senior review. Calcium chloride through a peripheral line risks tissue injury. In a patient taking digoxin, intravenous calcium decisions need specialist monitoring rather than reflex avoidance or unmonitored administration.
Chronic-treatment red flags include new polyuria, thirst, nausea, constipation, confusion or weakness suggesting hypercalcaemia; renal colic, haematuria or falling eGFR suggesting urinary complications; and abrupt symptoms after missed active vitamin D. During pregnancy, both maternal hypocalcaemia and hypercalcaemia can harm mother and fetus. Requirements can change quickly after delivery and during lactation, so continuing an antenatal dose without early checks may cause hypercalcaemia. Abrupt cessation of breastfeeding can also destabilize calcium. A patient unable to afford or obtain activated vitamin D is not safely controlled by advice alone and needs an accessible replacement and monitoring plan.
Indian Clinical Context
Indian practice spans high-volume thyroid centres, district hospitals and settings where ionized calcium, intact PTH or 24-hour urine calcium may not be available daily. The simplest safe postoperative pathway is serial symptom assessment with time-stamped calcium and early PTH where validated, plus a clear escalation threshold and discharge plan. Albumin-adjusted calcium is useful when ionized measurement is unavailable, but correction equations are unreliable in critical illness, pregnancy and major acid-base disturbance. Samples must not be delayed so long that stridor, seizure or arrhythmia goes untreated. Laboratories should state the calcium method and reference range, and clinicians should verify vitamin D units and calcium salt strength across brands.
Conventional treatment must be affordable and sustainable. Prescribe generic and brand names where confusion is likely, document elemental calcium per dose, and explain the difference between native and activated vitamin D in the patient's preferred language. Calcitriol and alfacalcidol are not interchangeable milligram-for-milligram with nutritional supplements. Tablet burden, constipation, fasting practices, limited refrigeration-free transport, rural travel and inconsistent pharmacy stock affect adherence. Provide an emergency card, recent calcium and creatinine results, current doses and a contact route rather than relying on memory.
Renal surveillance is easily missed when care focuses on serum calcium. Arrange creatinine and eGFR, phosphate, magnesium and periodic 24-hour urine calcium where feasible; investigate stone symptoms and use imaging selectively. Dietary advice should avoid indiscriminate severe calcium restriction and account for local salt intake and meal patterns. PTH replacement may be unavailable or unaffordable and should never displace optimized conventional care without product authorization and long-term follow-up. Pregnancy care needs joint endocrine-obstetric monitoring, including the early postpartum period, and neonatal teams should be told about maternal disease before delivery.
NMC Competency Mapping
Hypoparathyroidism connects endocrine physiology with emergency medicine, pharmacology, surgery, renal physiology, obstetrics and communication. Learners should explain PTH control of bone turnover, renal calcium reabsorption, phosphate excretion and calcitriol synthesis; predict the biochemical pattern of low calcium, high phosphate and inappropriately low PTH; and contrast true deficiency with vitamin D deficiency, chronic kidney disease and PTH resistance. NMC physiology and biochemistry endocrine competencies provide this mechanistic base, while Medicine competencies on calcium disorders require recognition, investigation and principles of management. Surgical integration should cover prevention, early recognition and handover after thyroid or parathyroid operations.
A graduating learner should assess airway and neuromuscular irritability, interpret ionized or albumin-adjusted calcium, request magnesium, phosphate, renal function, vitamin D and PTH, recognize ECG risk, and escalate severe symptomatic hypocalcaemia. Pharmacology should include elemental-calcium calculations, route and tissue risks of intravenous salts, activated versus native vitamin D, interactions and monitoring after dose change. Longitudinal care should include symptom targets, urinary calcium, renal function, pregnancy and counselling about an emergency plan.
An appropriate case-based assessment might present a patient twenty-four hours after thyroidectomy with perioral tingling, carpopedal spasm and a prolonged QT. The learner should call for monitored intravenous calcium, verify the preparation, check magnesium and PTH, and plan active vitamin D and follow-up. A second station can test chronic overtreatment through renal stones and hypercalciuria despite a low-normal serum calcium. Exact NMC competency codes and certification levels should be checked against the medical college's current 2024 CBME tables, not copied from unofficial coaching mappings.
Key Exam Pearls for NEET PG
Hypoparathyroidism produces hypocalcaemia with an inappropriately low or normal PTH and often hyperphosphataemia. Vitamin D deficiency and chronic kidney disease usually raise PTH. Severe hypomagnesaemia can suppress secretion and cause resistance, so refractory hypocalcaemia demands magnesium correction. Pseudohypoparathyroidism has high PTH because the target organ is resistant. Activating calcium-sensing receptor variants can cause hypocalcaemia with disproportionate hypercalciuria, making forced calcium normalization hazardous. The common adult cause is anterior neck surgery, but chronic postsurgical disease should not be declared before twelve months because delayed recovery occurs.
Tetany, seizure, laryngospasm, prolonged QT or arrhythmia requires monitored intravenous calcium gluconate. The high-yield adult loading regimen in Society guidance is 10–20 mL of 10% calcium gluconate in 50–100 mL 5% dextrose over ten minutes, repeated if necessary, followed by a titrated infusion when needed. Check ampoule strength: calcium chloride is not volume-equivalent and is usually central-line medicine. Correct magnesium and introduce activated vitamin D.
Chronic therapy aims for symptom relief with calcium at the lower end of normal, not a high-normal target. Use divided oral elemental calcium plus calcitriol or alfacalcidol, maintain native vitamin D and monitor phosphate, magnesium, creatinine, eGFR and 24-hour urinary calcium. Hypercalciuria can occur despite low-normal serum calcium because PTH's renal calcium-retaining action is missing. Consider reduced sodium, dose adjustment, thiazide monitoring and selected PTH replacement. PTH therapy can reduce pill burden and improve biochemical indices, but evidence for long-term kidney, fracture, calcification and mortality outcomes remains limited. During pregnancy, monitor more frequently, avoid unproven PTH analogues and reassess promptly after delivery and during lactation.
Frequently Asked Questions
Why can a person with hypoparathyroidism develop kidney stones despite a low-normal blood calcium?
Without PTH, the kidney loses an important signal to reabsorb calcium. Oral calcium and activated vitamin D can raise filtered calcium and urinary excretion even when serum calcium is kept low-normal. This is why treatment targets symptoms rather than high-normal calcium and why 24-hour urine calcium, kidney function and stone symptoms must be monitored alongside blood tests.
Which hypocalcaemia features require emergency intravenous calcium?
Laryngospasm or stridor, seizure, generalized tetany, significant QT prolongation, arrhythmia, haemodynamic instability, or severe symptoms at a calcium below the reference range require emergency monitored treatment. Society guidance also treats a calcium below about 1.9 mmol/L as severe. Obtain magnesium, phosphate, renal function and PTH samples, but do not postpone stabilization in an unstable patient.
Can chronic hypoparathyroidism be managed with ordinary vitamin D alone?
Usually not. PTH is required for efficient renal conversion of 25-hydroxyvitamin D to calcitriol, so established disease generally needs an activated analogue such as calcitriol or alfacalcidol plus individualized oral calcium. Native cholecalciferol or ergocalciferol is still used to maintain vitamin D stores, but it does not replace activated therapy. All doses require calcium, phosphate, magnesium and renal monitoring.
Is PTH replacement the best treatment for every adult with hypoparathyroidism?
No. Optimized calcium and activated vitamin D remain appropriate for many adults. Specialist PTH replacement may help when symptoms, biochemical instability, hypercalciuria, hyperphosphataemia, renal concerns or pill burden remain unacceptable. It improves several biochemical outcomes and can reduce supplements, but availability and cost vary, pregnancy safety is unestablished, and evidence for preventing long-term fractures, kidney disease or mortality is still limited.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic